Compare Eli Lilly And Co (LLY) vs United Parcel Service Inc (UPS) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

UPS stock trades at $112.97, down 4.03% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains strong profitability with 33.41% ROE and 5.94% net margin, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent quarters show consistent earnings beats, with Q2 2026 results expected on July 28, 2026. Analyst sentiment is divided with 42% buy ratings and consensus price target of $112.

UPS faces near-term headwinds from revenue pressure and Amazon's logistics expansion, but cost-cutting initiatives and healthcare investments provide growth catalysts. The stock's current valuation at 19x P/E appears reasonable given strong cash flow generation. Key risks include competitive threats and economic sensitivity, while dividend sustainability remains a focus with the $1.64 per share payout.